Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01266824 · ClinicalTrials.gov registry record · NA
Proparacaine and Mydriatic Eye Drops
A NA study, sponsored by Children's Hospital of Philadelphia.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT01266824: Clinical Trial NA study, sponsored by Children's Hospital of Philadelphia.
NCT01266824 is a NA study that was terminated before completion, run by Children's Hospital of Philadelphia. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01266824, a NA study, was terminated before completion, sponsored by Children's Hospital of Philadelphia.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
In this study, we will be evaluating whether premedication with an anesthetic eye drops leads to a decreased sensation of pain when given dilating eye drops prior to eye examinations to evaluate for retinopathy of prematurity in neonatal intensive care unit (NICU) infants.
Primary Outcome
Comparison of the change in Premature Infant Pain Profile (PIPP) scores from baseline to the time immediately following mydriatic drop administration between the groups of infants who do and do not receive Proparacaine eye drops prior to mydriatic drops. The PIPP score is a scale to determined pain response that was designed for use in preterm and term infants. It is based on both physiologic and behavioral changes exhibited by infants during the study period of 30s (facial changes, HR, O2 satur
Interventions
- DRUG Proparacaine Hydrochloride Ophthalmic Solution
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-08 |
| Phase | NA |
Why NCT01266824 stopped before completion
NCT01266824 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Proparacaine Hydrochloride Ophthalmic Solution is the first listed.
NCT01266824 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01266824 about?
NCT01266824 is a clinical study titled "Proparacaine and Mydriatic Eye Drops". In this study, we will be evaluating whether premedication with an anesthetic eye drops leads to a decreased sensation of pain when given dilating eye drops prior to eye examinations to evaluate for retinopathy of prematurity in neonatal intensive care unit (NICU) infants.
What is the current status of trial NCT01266824?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2010-12. Estimated completion is 2011-08.
What interventions are being tested in trial NCT01266824?
The interventions under investigation include: Proparacaine Hydrochloride Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT01266824?
This trial is sponsored by Children's Hospital of Philadelphia, which has 431 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01266824's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia